A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Clinical trial NCT06703021 · COMPLETED

Trial details

NCT number: NCT06703021
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Overweight Chronic Weight Management

Start date: 2024-12-20
Primary completion: 2026-01-12
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.